Quarterly report pursuant to Section 13 or 15(d)

Revenue - Narrative (Details)

v3.21.1
Revenue - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]      
Unbilled receivables, net $ 43,694   $ 22,358
Contract with customer, liability 16,000   $ 10,100
Contract with customer, liability, revenue recognized 860 $ 700  
Revenue, remaining performance obligation $ 188,000    
Sales Revenue, Net | Product Concentration Risk | Transferred at Point in Time      
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]      
Concentration risk, percentage 49.00% 43.00%  
Sales Revenue, Net | Product Concentration Risk | Transferred over Time      
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]      
Concentration risk, percentage 51.00% 57.00%